Clinical Trial Update: Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Eblasakimab in adults with moderate-to-severe atopic dermatitis who were previously treated with dupilumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Eblasakimab (eblasakimab)

Snippet

Sponsor: ASLAN Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: UNKNOWN